CRESCENT BIOPHARMA, INC.
CBIO$177M
Micro CapNASDAQPharmaceutical Preparations🇺🇸North AmericaWALTHAM41 employees
Drugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Jul 30, 2026
5wMarket Overview
Stock performance and key metrics
CBIO News
Catalyst Timeline
1 upcoming, 0 past
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
CR-001 | Phase 2 | Locally Advanced / Metastatic Solid Tumors | - | - |
Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply